Since Leqembi is dosed based on a patient’s weight and offered in single-use vials, about 5.8% of the drug dispensed will be ...
YourTango on MSN1d
The Symptom I Chalked Up To Old Age That Turned Out To Be Early Alzheimer's DiseaseZelik Bocknek is a retired business owner and lives in Toronto, Canada. Zelik is living with early Alzheimer’s disease and is ...
A simple tweak in available vial sizes of the breakthrough Alzheimer's drug Leqembi could save Medicare hundreds of millions ...
GlobalData on MSN11h
Siemens Healthineers gets CE Mark for Alzheimer’s PET analysis featuresCentiloid scoring and tau PET quantification are the two new features in the company’s syngo.PET software application.
Eli Lilly is making a series of investments in China to support its manufacturing and R&D operations. Gilead Sciences has ...
Australia's Therapeutic Goods Administration (TGA) has said it won't approve Eisai and Biogen's Alzheimer's disease therapy ...
About 6% of Leqembi (lecanemab) is discarded because patients are frequently prescribed doses lower than the size of the drug’s single-use vials. This waste costs Medicare about $1,600 a patient ...
Medicare could save millions of dollars every year by changing the way they package Alzheimer's medication.
European regulators have for the fourth time issued a negative opinion on PTC's Translarna. Elsewhere, Amylyx read out data ...
Neurophet to host Symposium featuring renowned expert in Alzheimer's disease treatment from the U.S.
Neurophet has specialized in developing solutions for diagnosis support, treatment guides, and treatment devices targeting ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback